Literature DB >> 25338430

Molecular mechanisms of peritoneal dialysis-induced microvascular vasodilation.

El Rasheid Zakaria, Asma Althani, Ashraf A Fawzi, Omar M Fituri.   

Abstract

Peritoneal dialysis (PD) solutions dilate microvessels by undefined mechanisms. This vasodilation directly affects ultrafiltration and solute exchange during a PD dwell and is thought to account for the variable mass transfer area coefficient for small solutes during a glucose-based hypertonic dwell. We hypothesized that PD-mediated vasodilation occurs by endothelium-dependent mechanisms that involve endothelium energy-dependent K+ channels (K(ATP)), adenosine A1 receptor activation, and NO release. We used intravital videomicroscopy to study 3 levels of microvessels (A1 inflow arterioles about 100 microm diameter to pre-capillary A3 arterioles 10 - 15 microm diameter) in the terminal ileum of anesthetized rats under control conditions in vivo in a tissue bath. Ileum was bathed with hypertonic mannitol or 2.5% glucose-based PD solution (Delflex: Fresenius Medical Care North America, Waltham, MA, U.S.A.) with or without topical application of individual or combined specific inhibitors of the endothelium-dependent dilation pathways.: NO (L-NMMA), prostaglandin I2 (mefenamic acid), endothelium hyperpolarizing factor (glibenclamide), and adenosine A1 receptor antagonist (DPCPX). The mannitol and PD solutions induced rapid and sustained peritoneal vasodilation whose magnitude depended on microvascular level and osmotic solute. Combined inhibition of endothelium-dependent dilation pathways completely abolished the mannitol-induced hyperosmolality-mediated dilation at all microvascular levels, but selectively eliminated the PD solution-mediated A3 dilation. The K(ATP) and adenosine receptor antagonists, individually or combined, remarkably attenuated dilation in the smaller pre-capillary arterioles; NO inhibition, alone or combined with K(ATP) and adenosine receptor antagonists, eliminated the PD solution-induced dilation. The cyclooxygenase pathway is not involved in PD-induced dilation. Solutions for PD dilate the visceral peritoneal microvasculature by endothelium-dependent mechanisms, primarily the NO pathway. Adenosine receptor-activated NO release and K(ATP) channel-mediated endothelium hyperpolarization significantly contribute to vasodilation in the smaller peritoneal pre-capillary arterioles.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25338430

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  6 in total

1.  Fluid Osmolarity Acutely and Differentially Modulates Lymphatic Vessels Intrinsic Contractions and Lymph Flow.

Authors:  Eleonora Solari; Cristiana Marcozzi; Daniela Negrini; Andrea Moriondo
Journal:  Front Physiol       Date:  2018-07-05       Impact factor: 4.566

2.  Correlation between Ultrafiltration Coefficient and Effective Lymphatic Absorption Rate in Continuous Ambulatory Peritoneal Dialysis Patients: A Possible Paradigm Shift.

Authors:  Reza Hekmat
Journal:  Iran J Med Sci       Date:  2019-07

Review 3.  Lymphatic Vessels and Their Surroundings: How Local Physical Factors Affect Lymph Flow.

Authors:  Eleonora Solari; Cristiana Marcozzi; Daniela Negrini; Andrea Moriondo
Journal:  Biology (Basel)       Date:  2020-12-11

Review 4.  The potential role of NFAT5 and osmolarity in peritoneal injury.

Authors:  Harald Seeger; Daniel Kitterer; Joerg Latus; Mark Dominik Alscher; Niko Braun; Stephan Segerer
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

5.  Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly.

Authors:  El Rasheid Zakaria; Bellal Joseph; Mohammad Hamidi; Muhammad Zeeshan; Abdelrahman Algamal; Faheem Sartaj; Maha Althani; Tassnim Fadl; Dana Madan
Journal:  Qatar Med J       Date:  2019-12-24

6.  Water removal during automated peritoneal dialysis assessed by remote patient monitoring and modelling of peritoneal tissue hydration.

Authors:  Joanna Stachowska-Pietka; Beata Naumnik; Ewa Suchowierska; Rafael Gomez; Jacek Waniewski; Bengt Lindholm
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.